Skip to main content
OpenTrials
Completed

NCT Number: NCT03092973

Carotid Intima Media Thickness (CIMT) in Epistaxis

Epistaxis is a very frequent emergency among adults and often needs specialised treatment in an ENT-department. Among others, atherosclerosis is often named as a reason for an increased risk for Epistaxis. To evaluate whether or not this is the case, the investigators examined the carotid intima media thickness via ultrasound in patients who were treated in the ENT-department of the University Hospital of Zurich.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • active or very recently active anterior or posterior epistaxis
  • at least 18 years old

Exclusion criteria

  • posttraumatic or postoperative epistaxis

Treatment and study plan

Ultrasound

Diagnostic Test

Primary outcomes

  1. Carotid Intima Media Thickness in Epistaxis vs. Controls

    Time frame: June 2017

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Carotid Intima Media Thickness in Patients With Epistaxis: a Surrogate Marker for Generalised Atherosclerosis

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Mar 28, 2017
Registry last updated
Oct 30, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.